| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.17 | 3e-07 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |